U.S. Court of Appeals for the Federal Circuit, 2023

Vifor Fresenius Medical Care Renal Pharma Ltd. v. Lupin Atlantis Holdings Sa

Vifor Fresenius Medical Care Renal Pharma Ltd. v. Lupin Atlantis Holdings Sa
U.S. Court of Appeals for the Federal Circuit · Decided February 7, 2023

Vifor Fresenius Medical Care Renal Pharma Ltd. v. Lupin Atlantis Holdings Sa

Opinion

Case: 22-2253 Document: 18 Page: 1 Filed: 02/07/2023

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD., VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE S.A.S., Plaintiffs-Appellees v. LUPIN ATLANTIS HOLDINGS SA, Defendant TEVA PHARMACEUTICALS USA, INC., Defendant-Appellant ______________________ 2022-2253 ______________________ Appeal from the United States District Court for the District of Delaware in No. 1:18-cv-00390-MN, Judge Maryellen Noreika. ______________________ ORDER The parties having so agreed, it is ordered that: (1) The proceeding is DISMISSED under Fed. R. App. P. 42 (b).

Case: 22-2253 Document: 18 Page: 2 Filed: 02/07/2023

2 VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD. V. LUPIN ATLANTIS HOLDINGS SA

(2) Each side shall bear their own costs.

FOR THE COURT February 7, 2023 Date /s/ Peter R. Marksteiner Peter R. Marksteiner Clerk of Court

ISSUED AS A MANDATE: February 7, 2023

Case-law data current through December 31, 2025. Source: CourtListener bulk data.